0.12%| Prev Close: | 0.55 |
|---|---|
| Open: | N/A |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 4.88 |
| Beta: | 1.23 |
| Next Earnings Date: | N/A |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 0.34 - 0.90 |
| Volume: | 0 |
| Avg Vol (3m): | 0 |
| Market Cap: | 20.48M |
| P/E (ttm): | 0.71 |
| EPS (ttm): | 0.77 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- China Botanic trading halted, pending newstheflyonthewall.com(Wed, May 8)
- China Botanic Pharmaceutical Inc. Announces Receipt of Delisting NoticePR Newswire(Tue, May 7)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online(Tue, May 7)
- China Botanic trading halted, pending newsat theflyonthewall.com(Thu, May 2)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial StatementsEDGAR Online(Tue, Apr 9)
- Slovenia Bailout Signaled by Worsening Debt Swaps: Euro Creditat Bloomberg(Sun, Apr 7)
- China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing LetterPR Newswire(Tue, Apr 2)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online(Tue, Apr 2)
- China Botanic Pharmaceutical Inc. Announces Acceptance of its Plan of Compliance by NYSE MKT LLCPR Newswire(Thu, Mar 7)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online(Tue, Feb 5)
- China Botanic receives notice of failure to satisfy NYSE listing requirementsat theflyonthewall.com(Tue, Feb 5)
- China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing RequirementsPR Newswire(Tue, Feb 5)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, Jan 23)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule oEDGAR Online(Tue, Jan 15)
- CHINA BOTANIC PHARMACEUTICAL Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements andEDGAR Online(Fri, Dec 28)
Press Releases
- China Botanic Pharmaceutical Inc. Announces Receipt of Delisting NoticePR Newswire(Tue, May 7)
- China Botanic Pharmaceutical Inc. Announces Receipt of Notice of Failure to Satisfy Continued Listing LetterPR Newswire(Tue, Apr 2)
- China Botanic Pharmaceutical Inc. Announces Acceptance of its Plan of Compliance by NYSE MKT LLCPR Newswire(Thu, Mar 7)
Reports
- China Botanic Pharmaceutical Inc: Business description, financial summary, 3yr...Reuters Investment Profile(May 18)
- ValuEngine Industry Report for Medical-generic DrugsValuEngine, Inc.(May 3)
- China Botanic Pharmaceutical Inc. (CBP) - Financial Analysis ReviewGlobalData(Apr 19)